Mayne Pharma Group (ASX:MYX) Hits New 1-Year Low at $0.42

Mayne Pharma Group Ltd (ASX:MYX)’s share price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as A$0.42 ($0.29) and last traded at A$0.42 ($0.29), with a volume of 3346517 shares changing hands. The stock had previously closed at A$0.42 ($0.30).

The firm’s fifty day moving average price is A$0.45 and its 200-day moving average price is A$0.49. The company has a current ratio of 2.23, a quick ratio of 1.64 and a debt-to-equity ratio of 36.47. The firm has a market cap of $637.35 million and a price-to-earnings ratio of -2.11.

In other news, insider Scott Richards 2,555,805 shares of the business’s stock in a transaction on Monday, December 9th.

About Mayne Pharma Group (ASX:MYX)

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers.

Further Reading: Why are gap-down stocks important?

Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.